Non-Opioid Analgesic Medications for Pain Management Pt. 2 (Muzyk)

0.0(0)
Studied by 0 people
call kaiCall Kai
Locked
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/36

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 9:16 PM on 8/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

37 Terms

1
New cards

Which drug classes are first-line for neuropathic pain?

antidepressants & anticonvulsants

2
New cards

T/F: Antidepressants and anticonvulsants are not combined with non-opioids and opioids

False

3
New cards

TCAs (amitriptyline, desipramine, nortriptyline) should be initiated at low doses then titrated. What is the initial dosing range?

10-25 mg qHS

4
New cards

TCAs (amitriptyline, desipramine, nortriptyline) should be initiated at low doses then titrated. What is the titrated dosing range of these drugs for neuropathic pain?

50-150 mg qHS

5
New cards

At what doses do TCAs have increased risk of cardiovascular/ anticholinergic AEs?

> 100 mg

6
New cards

T/F: TCAs are not recommended in elderly (> 65) patients due to increased risk of falls and cognitive impairment.

True

7
New cards

____ are safer than TCAs in older adults and those with cardiovascular disease;

SNRIs (duloxetine, venlafaxine, milnacipran)

8
New cards

____ is FDA-approved for chronic musculoskeletal pain

duloxetine

9
New cards

Watch for CYP450 interactions and serotonin syndrome with either class (TCAs & SNRIs); analgesic effect takes about 1 week and may continue increasing; taper over ___ to avoid withdrawal

2 weeks

10
New cards

____ and ____ have the best evidence in diabetic neuropathy and postherpetic neuralgia

gabapentin, pregabalin

11
New cards

T/F: Gabapentin and pregabalin do not require renal dose adjustments

False

12
New cards

Which gabapentinoid has a higher bioavailability and potency?

pregabalin

13
New cards

Pregabalin carries abuse-potential/opioid-potentiation concerns. What schedule is it?

C-V

14
New cards

Gradual titrations of anticonvulsants minimize major ADEs such as...

drowsiness, dizziness, ataxia

15
New cards

T/F: Abruptly discontinuing anticonvulsants can cause seizures

True

16
New cards

Carbamazepine is FDA-approved specifically for trigeminal neuralgia; other anticonvulsants have ___ evidence but may be tried after better-studied options fail

limited

17
New cards

___ agents treat neuromuscular spasticity (CP, MS, spinal cord injury) long-term

antispastic

18
New cards

___ agents treat acute musculoskeletal spasm short-term (2-3 weeks max)

antispasmodic

19
New cards

T/F: Antispasmodics are effective for spasticity

False

20
New cards

Which agents are first-line for non-radicular low back pain?

NSAIDs

21
New cards

Which agents are second-line for non-radicular low back pain?

antispasmodics

22
New cards

Why should antispasmodics be used cautiously when combined with opioids?

antispasmodics cause drowsiness/dizziness

23
New cards

T/F: Cyclobenzaprine 5 mg is as effective as 10 mg with fewer AEs

True

24
New cards

Carisoprodol, chlorzoxazone, and metaxalone each have distinct AE profiles.

What is the AE of chlorzoxazone due to chronic use (> 1 month)?

rare fatal hepatocellular injury

25
New cards

Carisoprodol, chlorzoxazone, and metaxalone each have distinct AE profiles.

What is the AE of carisoprodol?

dependence/withdrawal

26
New cards

Carisoprodol, chlorzoxazone, and metaxalone each have distinct AE profiles.

What is the AE of metaxalone?

nausea, rash, pruritus, LFT elevations

27
New cards

Why is carisoprodol (Soma) a C-IV?

Metabolized to meprobamate — a carbamate with barbiturate-like GABA-A activity and dependence/withdrawal profile

28
New cards

Which non-opioid analgesics are used for cancer pain, refractory neuropathic pain, RA pain, and epidural injection?

corticosteroids

29
New cards

T/F: Corticosteroids are used routinely despite their adverse effects

False

30
New cards

T/F: Adjuvant therapy goals are to reduce pain, maintain/improve function, and reduce or maintain the analgesic dose — with monitoring tailored to each agent's specific AEs

True

31
New cards

What is the labeled dosing for lidocaine 5% patches?

12 hours on then 12 hours off

32
New cards

What is the maximum number of lidocaine patches to wear per day?

3 patches/day

33
New cards

What is the MOA of capsaisin?

depletes substance P

34
New cards

The 8% capsaicin patch (Qutenza) is applied by a healthcare professional after EMLA pretreatment and repeated every 3 months

How long is the patch worn to treat diabetic peripheral neuralgia (DPN) of the feet?

30 min

35
New cards

The 8% capsaicin patch (Qutenza) is applied by a healthcare professional after EMLA pretreatment and repeated every 3 months

How long is the 8% capsaicin patch worn to treat post herpetic neuralgia (PHN)?

60 min

36
New cards

T/F: The 8% capsaicin patch (Qutenza) may cause intense burning and hypertension

True

37
New cards

Why are topical non-NSAID analgesics useful options for when systematic therapy is limited by comorbidities?

they have minimal systematic absorption